IBDEI0OT ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11839,1,3,0)
 ;;=3^BMI 39.0-39.9
 ;;^UTILITY(U,$J,358.3,11839,1,4,0)
 ;;=4^V85.39
 ;;^UTILITY(U,$J,358.3,11839,2)
 ;;=^332906
 ;;^UTILITY(U,$J,358.3,11840,0)
 ;;=V85.41^^55^688^18
 ;;^UTILITY(U,$J,358.3,11840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11840,1,3,0)
 ;;=3^BMI 40.0-44.9
 ;;^UTILITY(U,$J,358.3,11840,1,4,0)
 ;;=4^V85.41
 ;;^UTILITY(U,$J,358.3,11840,2)
 ;;=^339691
 ;;^UTILITY(U,$J,358.3,11841,0)
 ;;=V85.42^^55^688^19
 ;;^UTILITY(U,$J,358.3,11841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11841,1,3,0)
 ;;=3^BMI 45.0-49.9
 ;;^UTILITY(U,$J,358.3,11841,1,4,0)
 ;;=4^V85.42
 ;;^UTILITY(U,$J,358.3,11841,2)
 ;;=^339692
 ;;^UTILITY(U,$J,358.3,11842,0)
 ;;=V85.43^^55^688^20
 ;;^UTILITY(U,$J,358.3,11842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11842,1,3,0)
 ;;=3^BMI 50.0-59.9
 ;;^UTILITY(U,$J,358.3,11842,1,4,0)
 ;;=4^V85.43
 ;;^UTILITY(U,$J,358.3,11842,2)
 ;;=^339693
 ;;^UTILITY(U,$J,358.3,11843,0)
 ;;=V85.44^^55^688^21
 ;;^UTILITY(U,$J,358.3,11843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11843,1,3,0)
 ;;=3^BMI 60.0-69.9
 ;;^UTILITY(U,$J,358.3,11843,1,4,0)
 ;;=4^V85.44
 ;;^UTILITY(U,$J,358.3,11843,2)
 ;;=^339694
 ;;^UTILITY(U,$J,358.3,11844,0)
 ;;=V85.45^^55^688^22
 ;;^UTILITY(U,$J,358.3,11844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11844,1,3,0)
 ;;=3^BMI 70 and Over
 ;;^UTILITY(U,$J,358.3,11844,1,4,0)
 ;;=4^V85.45
 ;;^UTILITY(U,$J,358.3,11844,2)
 ;;=^339695
 ;;^UTILITY(U,$J,358.3,11845,0)
 ;;=308.9^^55^689^1
 ;;^UTILITY(U,$J,358.3,11845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11845,1,3,0)
 ;;=3^Acute Stress Reaction NOS
 ;;^UTILITY(U,$J,358.3,11845,1,4,0)
 ;;=4^308.9
 ;;^UTILITY(U,$J,358.3,11845,2)
 ;;=^268303
 ;;^UTILITY(U,$J,358.3,11846,0)
 ;;=V15.81^^55^689^8
 ;;^UTILITY(U,$J,358.3,11846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11846,1,3,0)
 ;;=3^Non-Compliant/Hazards to Health
 ;;^UTILITY(U,$J,358.3,11846,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,11846,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,11847,0)
 ;;=401.1^^55^689^2
 ;;^UTILITY(U,$J,358.3,11847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11847,1,3,0)
 ;;=3^Benign Hypertension
 ;;^UTILITY(U,$J,358.3,11847,1,4,0)
 ;;=4^401.1
 ;;^UTILITY(U,$J,358.3,11847,2)
 ;;=^269591
 ;;^UTILITY(U,$J,358.3,11848,0)
 ;;=401.9^^55^689^6
 ;;^UTILITY(U,$J,358.3,11848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11848,1,3,0)
 ;;=3^Hypertension NOS
 ;;^UTILITY(U,$J,358.3,11848,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,11848,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,11849,0)
 ;;=414.01^^55^689^3
 ;;^UTILITY(U,$J,358.3,11849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11849,1,3,0)
 ;;=3^Cor Atheroscl Natv C Vsl
 ;;^UTILITY(U,$J,358.3,11849,1,4,0)
 ;;=4^414.01
 ;;^UTILITY(U,$J,358.3,11849,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,11850,0)
 ;;=272.4^^55^689^5
 ;;^UTILITY(U,$J,358.3,11850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11850,1,3,0)
 ;;=3^Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,11850,1,4,0)
 ;;=4^272.4
 ;;^UTILITY(U,$J,358.3,11850,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,11851,0)
 ;;=530.81^^55^689^4
 ;;^UTILITY(U,$J,358.3,11851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11851,1,3,0)
 ;;=3^Esophageal Reflux
 ;;^UTILITY(U,$J,358.3,11851,1,4,0)
 ;;=4^530.81
 ;;^UTILITY(U,$J,358.3,11851,2)
 ;;=^295749
 ;;^UTILITY(U,$J,358.3,11852,0)
 ;;=780.57^^55^689^9
 ;;^UTILITY(U,$J,358.3,11852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11852,1,3,0)
 ;;=3^Sleep Apnea NOS
 ;;^UTILITY(U,$J,358.3,11852,1,4,0)
 ;;=4^780.57
 ;;^UTILITY(U,$J,358.3,11852,2)
 ;;=^332928
 ;;^UTILITY(U,$J,358.3,11853,0)
 ;;=244.9^^55^689^7
 ;;^UTILITY(U,$J,358.3,11853,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI0OT
